The National Institutes of Health is launching the Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge to seek innovative approaches that modulate RNA for disease treatment.
Beginning in 2026, the A. Douglas Kinghorn Award for Best Perspective or Review will celebrate scholarship that helps define and anticipate emerging scientific trends in the field.